diabetic nephropathy

Open Access
Empagliflozin and Cardiovascular and Kidney Outcomes across KDIGO Risk Categories
Adeera Levin, Vlado Perkovic, David C. Wheeler, Stefan Hantel, Jyothis T. George, Maximilian von Eynatten, Audrey Koitka-Weber, Christoph Wanner and on behalf of the EMPA-REG OUTCOME Investigators

CJASN September 2020, CJN.14901219; DOI: https://doi.org/10.2215/CJN.14901219

Add to Selected Citations
Open Access
The Use of Genomics to Drive Kidney Disease Drug Discovery and Development
Dermot F. Reilly and Matthew D. Breyer

CJASN September 2020, 15 (9) 1342-1351; DOI: https://doi.org/10.2215/CJN.11070919

Add to Selected Citations
You have accessRestricted Access
The Feasibility and Safety of Obtaining Research Kidney Biopsy Cores in Patients with Diabetes
Jonathan J. Hogan, Jonathan G. Owen, Shira J. Blady, Salem Almaani, Rupali S. Avasare, Shweta Bansal, Oliver Lenz, Randy L. Luciano, Samir V. Parikh, Michael J. Ross, Deep Sharma, Harold Szerlip, Shikha Wadhwani, Raymond R. Townsend, Matthew B. Palmer, Katalin Susztak, Amy K. Mottl and for the TRIDENT Study Investigators

CJASN July 2020, 15 (7) 1024-1026; DOI: https://doi.org/10.2215/CJN.13061019

Add to Selected Citations
Open Access
SONAR
Michael Walsh

CJASN June 2020, 15 (6) 889-891; DOI: https://doi.org/10.2215/CJN.08540719

Add to Selected Citations
You have accessRestricted Access
Metabolic Disorders with Kidney Transplant
Elizabeth Cohen, Maria Korah, Glenda Callender, Renata Belfort de Aguiar and Danielle Haakinson

CJASN May 2020, 15 (5) 732-742; DOI: https://doi.org/10.2215/CJN.09310819

Add to Selected Citations
You have accessRestricted Access
Liraglutide for the Treatment of Type 2 Diabetes and Safety in Diabetic Kidney Disease
David Z. Cherney and Katherine R. Tuttle

CJASN April 2020, 15 (4) 444-446; DOI: https://doi.org/10.2215/CJN.01260120

Add to Selected Citations
You have accessRestricted Access
Carbamylated Lipoproteins and Progression of Diabetic Kidney Disease
Kathryn C.B. Tan, Ching-Lung Cheung, Alan C.H. Lee, Joanne K.Y. Lam, Ying Wong and Sammy W.M. Shiu

CJASN March 2020, 15 (3) 359-366; DOI: https://doi.org/10.2215/CJN.11710919

Add to Selected Citations
Open Access
Proteomics and Metabolomics in Kidney Disease, including Insights into Etiology, Treatment, and Prevention
Ruth F. Dubin and Eugene P. Rhee

CJASN March 2020, 15 (3) 404-411; DOI: https://doi.org/10.2215/CJN.07420619

Add to Selected Citations
Open Access
Sodium Glucose Cotransporter 2 Inhibition Heralds a Call-to-Action for Diabetic Kidney Disease
Katherine R. Tuttle, David Z. Cherney and on behalf of the Diabetic Kidney Disease Task Force of the American Society of Nephrology

CJASN February 2020, 15 (2) 285-288; DOI: https://doi.org/10.2215/CJN.07730719

Add to Selected Citations
Open Access
Preserving Kidney Function Instead of Replacing It
Alan S. Kliger, Frank C. Brosius and on behalf of the Diabetic Kidney Disease Task Force of the American Society of Nephrology*

CJASN January 2020, 15 (1) 129-131; DOI: https://doi.org/10.2215/CJN.07820719

Add to Selected Citations

Main menu

User menu

Search

diabetic nephropathy

Pages

About

Author Information

More information